NCT01798017View on ClinicalTrials.gov

Introducing Mifepristone-Misoprostol for Menstrual Regulation in Public Sector Facilities in Bangladesh

PHASE4CompletedINTERVENTIONAL

Enrollment

1,738

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

June 30, 2015

Study Completion Date

August 31, 2015

Conditions

Menstrual Regulation

Interventions

DRUG

Mifepristone and misoprostol

Women will receive 200mg mifepristone followed in 24-48h by 800mcg bucccal misoprsotol

Trial Locations (8)

Unknown

Aminbazar Rural Dispensary, Aminbazar

MCH-Unit, Upazilla Health Center, Savar Upazila

Tetulzhora UH&FWC, Tetuljhora

Chartarapur UH & FWC, Chandrapur

Goyeshpur UH &FWC, Goyespur

MCH Unit, Sadar Upazilla, Pābna

Pabna MCWC, Pābna

Mohammadpur Fertility Services and Training Center, Dhaka

All Listed Sponsors

lead

Gynuity Health Projects

OTHER

NCT01798017 - Introducing Mifepristone-Misoprostol for Menstrual Regulation in Public Sector Facilities in Bangladesh | Biotech Hunter | Biotech Hunter